Stock Chart

MET

$94.35 +0.20%
Score: 51.5 HOLD
LEAPs: SELL $95
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $95
Premium: $10.49
Expiry: Sep 17, 2027
Target: $97
Score: -77

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.91x (vs SPY: 0.9x | vs QQQ: 0.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 01, 2026
Descending Triangle weak / forming — below our quality gate quality 54/100
A Descending Triangle is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Break direction historically ~even (52% up, n=87) — scenario shown, not a forecast
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About MET - MetLife, Inc.

MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading …

Key Statistics

Market Cap $60B
P/E Ratio 18.25
Dividend Yield 0.02%

This MET stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MET's price movements with trendlines, gamma walls, and key support/resistance levels.